Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $14.68 ($146,800)
  7. 4 Open-market sale Chief Business Officer sold 400 shares at $20.00 ($8,000)
  8. 4 Open-market sale Chief Medical Officer sold 4,000 shares at $20.00 ($80,000)
  9. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $19.08 ($190,800)
  10. 4 Open-market sale Chief Development Officer sold 7,500 shares at $15.00 ($112,500)
  11. 4 Open-market sale Chief Medical Officer sold 2,000 shares at $16.00 ($32,000)
  12. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $14.19 ($141,900)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale 10% owner sold 650,000 shares at $17.90 ($11,635,000)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 16 · 301 filings